Literature DB >> 24150706

Diagnosis of subretinal neovascularization associated with idiopathic juxtafoveal retinal telangiectasia - fluorescein angiography versus spectral-domain optical coherence tomography.

Jay Chhablani1, Kopal Mithal, Harsha Rao, Raja Narayanan.   

Abstract

BACKGROUND: To compare ability of fluorescein angiography (FFA) and spectral-domain optical coherence tomography (SD-OCT) to diagnose subretinal neovascularization (SRNV) secondary to idiopathic juxtafoveal retinal telangiectasia (IJRT) type 2A.
METHODS: Two masked observers evaluated FFA and SD-OCT images separately to diagnose the presence of SRNV in 65 eyes of 36 patients. A third masked observer diagnosed SRNV on color fundus photo. Presence of SRNV on color fundus photo was defined as presence of subretinal hemorrhage, thickening of retina, and/or visible membrane at the macula. Presence of SRNV on FFA was defined when there was hyperfluorescence in early phase with increase in intensity and size in the late phase; presence of membrane, large irregular lesion, hypofluorescence due to subretinal haemorrhage. SRNV on SD-OCT was defined as the presence of thickening of the retinal pigment epithelium-choriocapillaris complex with or without intraretinal fluid or subretinal fluid and associated with intraretinal hyperreflective area with retinal thickening.
RESULTS: Interobserver agreement (Kappa) for diagnosis of SRNV on FFA and SD-OCT was 0.373 (95 % CI, 0.106-0.617) and 0.775 (95 % CI, 0.612-0.899) respectively. The sensitivity and specificity of FFA were 52.3 % and 70.0 % respectively. With regard to SD-OCT, the sensitivity and specificity were 72.7 % and 64.1 % respectively in reference to color photograph. The negative predictive value (NPV) of SD-OCT (80.6 %) was higher than FFA (73.7 %). When we considered only the presence of subretinal hemorrhage on color photograph as a confirmed diagnosis of SRNV and compared the diagnostic ability of FFA and SD-OCT, we found that the FFA had poor sensitivity (58.3 %) but a better specificity (71.8 %) than SD-OCT, which had sensitivity of 75 % and specificity of 64 % (Tables 1 and 2). However, the negative predictive value (NPV) of SD-OCT (89.29 %) was slightly better than FFA (84.85 %).
CONCLUSION: Interobserver agreement between the observers was better for SD-OCT than for FFA in making the diagnosis of SRNV. SD-OCT is a better diagnostic modality than FFA for ruling out the presence of SRNV.

Entities:  

Mesh:

Year:  2013        PMID: 24150706     DOI: 10.1007/s00417-013-2491-4

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  12 in total

1.  Optical coherence tomography findings in nonproliferative group 2a idiopathic juxtafoveal retinal telangiectasis.

Authors:  Steven M Cohen; Mark L Cohen; Fayssal El-Jabali; Scott E Pautler
Journal:  Retina       Date:  2007-01       Impact factor: 4.256

2.  Optical coherence tomography characteristics of group 2A idiopathic parafoveal telangiectasis.

Authors:  Juan G Sanchez; Reinaldo A Garcia; Lihteh Wu; Maria H Berrocal; Federico Graue-Wiechers; Francisco J Rodriguez; Violeta Robledo; Carmen Lizana; Zlatco Piskulich; Aristides J Mendoza; Wandsy Velez-Vazquez; J Fernando Arevalo
Journal:  Retina       Date:  2007 Nov-Dec       Impact factor: 4.256

3.  Fundus autofluorescence patterns in type 2A idiopathic juxtafoveolar retinal telangiectasis.

Authors:  Jay Kumar Chhablani; Raja Narayanan
Journal:  Eur J Ophthalmol       Date:  2012 May-Jun       Impact factor: 2.597

4.  Long-term juxtafoveal retinal telangiectasia.

Authors:  Robert C Watzke; Michael L Klein; James C Folk; Samuel G Farmer; Richard S Munsen; Robert J Champfer; K R Sletten
Journal:  Retina       Date:  2005-09       Impact factor: 4.256

5.  Type 2 idiopathic macular telangiectasia.

Authors:  Dhananjay Shukla; Shashank R Gupta; Nithya Neelakantan; Sachin Tiwari; Sumi Gupta; Aditi R Patwardhan; Thayyil B Soubhya
Journal:  Retina       Date:  2012-02       Impact factor: 4.256

6.  Optical coherence tomography in group 2A idiopathic juxtafoveolar retinal telangiectasis.

Authors:  Alain Gaudric; Ghislaine Ducos de Lahitte; Salomon Y Cohen; Pascale Massin; Belkacem Haouchine
Journal:  Arch Ophthalmol       Date:  2006-10

7.  Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study.

Authors:  J D Gass; B A Blodi
Journal:  Ophthalmology       Date:  1993-10       Impact factor: 12.079

8.  Characterization of idiopathic macular telangiectasia type 2 by fundus fluorescein angiography in Indian population.

Authors:  R Narayanan; A B Majji; N Hussain; A Hussain; S Jalali; A Mathai; V A Shah
Journal:  Eur J Ophthalmol       Date:  2008 Jul-Aug       Impact factor: 2.597

9.  Confocal blue reflectance imaging in type 2 idiopathic macular telangiectasia.

Authors:  Peter Charbel Issa; Tos T J M Berendschot; Giovanni Staurenghi; Frank G Holz; Hendrik P N Scholl
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-03       Impact factor: 4.799

10.  Baseline characteristics of participants in the natural history study of macular telangiectasia (MacTel) MacTel Project Report No. 2.

Authors:  Traci E Clemons; Marc C Gillies; Emily Y Chew; Alan C Bird; Tunde Peto; Maria J Figueroa; Molly W Harrington
Journal:  Ophthalmic Epidemiol       Date:  2010 Jan-Feb       Impact factor: 1.648

View more
  6 in total

1.  [Optical coherence tomography for differentiation of parathyroid gland tissue].

Authors:  R Ladurner; K Hallfeldt; N Al Arabi; J Gallwas; U Mortensen; S Sommerey
Journal:  Chirurg       Date:  2016-05       Impact factor: 0.955

2.  Fluorescein angiography versus spectral domain optical coherence tomography in idiopathic juxtafoveal retinal telangiectasia.

Authors:  Jay Chhablani; Raja Narayanan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-09-09       Impact factor: 3.117

3.  Diagnosis of subretinal neovascularization associated with idiopathic juxtafoveal retinal telangiectasia - fluorescein angiography versus spectral-domain optical coherence tomography - can we choose?

Authors:  Shalini Singh; Manisha Agarwal; Ramesh Venkatesh; Rahul Mayor
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-10-12       Impact factor: 3.117

4.  Intravitreal anti-VEGF treatment for subretinal neovascularisation secondary to type 2 idiopathic juxtafoveolar telangiectasia.

Authors:  Teresa Barth; Florian Zeman; Horst Helbig; Maria-Andreea Gamulescu
Journal:  Int Ophthalmol       Date:  2017-01-21       Impact factor: 2.031

5.  The preproliferative stage in type 2 macular telangiectasia (MacTel type 2).

Authors:  Ramesh Venkatesh; Nikitha Gurram Reddy; Pranjal Mishra; Arpitha Pereira; Deepashri Mutalik; Sameeksha Agrawal; Abhishek Bhatt; Naresh Kumar Yadav; Jay Chhablani
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-08-19       Impact factor: 3.117

Review 6.  Macular Telangiectasia Type 2: A Comprehensive Review.

Authors:  Kiran Chandra Kedarisetti; Raja Narayanan; Michael W Stewart; Nikitha Reddy Gurram; Arshad M Khanani
Journal:  Clin Ophthalmol       Date:  2022-10-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.